Avalo Therapeutics, Inc.
10 clinical trials · Sponsor
◉ Watch Avalo Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa (NCT06603077) | Avalo Therapeutics, Inc. | 2024-09-16 |
| A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma. (NCT05288504) | Avalo Therapeutics, Inc. | 2022-02-24 |
| A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations (NCT04994002) | Avalo Therapeutics, Inc. | 2021-09-03 |
| Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma (NCT04671251) | Avalo Therapeutics, Inc. | 2020-12-15 |
Track Avalo Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.